Diana Shcherbinina's Contact Details

Diana Shcherbinina's Company Details

Opened in December, 2008 on the basis of State Institution Research and Production Developmental Laboratory for Cardiovascular Reconstructive Surgery. The Institute's goals are to obtain new and extend existing knowledge in cardiology, angiology and cardiovascular surgery in order to preserve and strengthen the population's health, improve healthcare system and boost medical science development. The Institute consists of 4 research departments, which include 18 laboratories, and a clinic having cardiac surgery and cardiology divisions. The Institute's staff includes 100 researchers (70% young researchers), of those 60 have a PhD degree. The Institute conducts registry studies on major cardiovascular diseases and has participated in more than 40 international randomized placebo-controlled clinical trials. The results of biomedical research are used for heart valve and vessel grafts production. The Institute is looking for partners to conduct studies on the diagnosis and treatment of cardiovascular diseases implementing nanotechnology approaches and the principles of regenerative medicine. Some examples of the topics considered for collaboration are as follows: biocompatible polymers and the coating improving biocompatibility, nanosized particles for the drug delivery into subcellular organelles, diagnosis based on visualization with quantum dots, diagnosis and treatment of atherosclerosis using nanotechnology approaches.